Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase

This publication has 12 references indexed in Scilit:

• Molecular and cellular biology of cholinesterases
  Published by Elsevier ,2003
• Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp
  Science, 1996
• Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives
  Bioorganic & Medicinal Chemistry Letters, 1995
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.
  Proceedings of the National Academy of Sciences, 1993
• A Controlled Trial of Tacrine in Alzheimer's Disease
  JAMA, 1992
• Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain of the inhibition kinetics
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
• Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C
  Journal of Molecular Biology, 1988
• Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs
  Neuropharmacology, 1987
• The Cholinergic Hypothesis of Geriatric Memory Dysfunction
  Science, 1982
• A new and rapid colorimetric determination of acetylcholinesterase activity
  Biochemical Pharmacology, 1961